| P2093 | author name string | Ching-Hsien Chen | |
| | David C Yang | |
| | Lon Wolf R Fong | |
| P2860 | cites work | Direct involvement of protein myristoylation in myristoylated alanine-rich C kinase substrate (MARCKS)-calmodulin interaction. | Q44594134 |
| | Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). | Q45263165 |
| | MARCKS actin-binding capacity mediates actin filament assembly during mitosis in human hepatic stellate cells. | Q53171098 |
| | Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. | Q53305406 |
| | Dissociation of phosphorylation and translocation of a myristoylated protein kinase C substrate (MARCKS protein) in C6 glioma and N1E-115 neuroblastoma cells. | Q55482973 |
| | The Effector Domain of Myristoylated Alanine-rich C Kinase Substrate Binds Strongly to Phosphatidylinositol 4,5-Bisphosphate | Q57371944 |
| | The bi-directional translocation of MARCKS between membrane and cytosol regulates integrin-mediated muscle cell spreading | Q57375243 |
| | MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin | Q24323363 |
| | Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation | Q28186288 |
| | MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro | Q28215052 |
| | Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters spin-labeled phosphatidylinositol 4,5-bisphosphate in lipid bilayers | Q28217297 |
| | The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components | Q28253543 |
| | The MARCKS family of protein kinase-C substrates | Q28273578 |
| | Expression of MARCKS effector domain mutants alters phospholipase D activity and cytoskeletal morphology of SK-N-MC neuroblastoma cells | Q28575172 |
| | Dynamic adhesions and MARCKS in melanoma cells | Q28579253 |
| | The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions | Q29010955 |
| | Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins | Q30447412 |
| | The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells | Q30497948 |
| | MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines | Q33597596 |
| | Tumor necrosis factor alpha modifies agonist-dependent responses in human neutrophils by inducing the synthesis and myristoylation of a specific protein kinase C substrate | Q33706259 |
| | Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation | Q33781030 |
| | PhosphoMARCKS drives motility of mouse melanoma cells | Q33814631 |
| | Activation of protein kinase C isoforms and its impact on diabetic complications | Q33881442 |
| | Role of AKT signaling in DNA repair and clinical response to cancer therapy | Q34193741 |
| | Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. | Q34398956 |
| | Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein. | Q34805664 |
| | Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. | Q34857146 |
| | Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications | Q34987170 |
| | The MARCKS brothers: a family of protein kinase C substrates | Q35476852 |
| | Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment | Q36020972 |
| | Directed migration of mouse macrophages in vitro involves myristoylated alanine-rich C-kinase substrate (MARCKS) protein | Q36188854 |
| | Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein | Q36202835 |
| | A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis | Q36244135 |
| | A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils | Q36703999 |
| | Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation | Q36835981 |
| | Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway | Q36849876 |
| | In Vitro Neutrophil Migration Requires Protein Kinase C-Delta (δ-PKC)-Mediated Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Phosphorylation. | Q36954876 |
| | A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro | Q37101145 |
| | MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma | Q37130116 |
| | Protein kinase C intervention: the state of play | Q37398291 |
| | MARCKS protein overexpression in inflammatory breast cancer | Q37701585 |
| | miR‑34c‑3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS. | Q37722111 |
| | Regulation of mucin secretion and inflammation in asthma: a role for MARCKS protein? | Q37833718 |
| | Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. | Q37950261 |
| | Contribution of individual PKC isoforms to breast cancer progression | Q37957811 |
| | Peptide therapeutics: current status and future directions | Q38275750 |
| | Myoblast migration is prevented by a calpain-dependent accumulation of MARCKS. | Q38346034 |
| | Molecular basis of resistance to proteasome inhibitors in hematological malignancies | Q38351357 |
| | RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise? | Q38688625 |
| | MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression | Q38742442 |
| | Secretome protein signature of human pancreatic cancer stem-like cells | Q38796126 |
| | Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity | Q38927046 |
| | Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma | Q38960661 |
| | Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target | Q38976447 |
| | Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival | Q39012262 |
| | MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Q39139786 |
| | Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo | Q39200403 |
| | FDA-Approved Oligonucleotide Therapies in 2017. | Q39214058 |
| | Targeting PI3K Signaling in Combination Cancer Therapy. | Q39441303 |
| | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. | Q39756253 |
| | Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression | Q39796348 |
| | MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells | Q39870137 |
| | Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma | Q40253359 |
| | PKC phosphorylates MARCKS Ser159 not only directly but also through RhoA/ROCK. | Q40283261 |
| | Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. | Q40476398 |
| | Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway | Q40595058 |
| | Myristoylated alanine-rich C-kinase substrate (MARCKS) protein regulation of human neutrophil migration. | Q40684672 |
| | Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. | Q40724768 |
| | GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism | Q40871328 |
| | Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Mutational analysis provides evidence for complex interactions | Q41336364 |
| | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. | Q41526004 |
| | Regulation of a Coupled MARCKS-PI3K Lipid Kinase Circuit by Calmodulin: Single-Molecule Analysis of a Membrane-Bound Signaling Module | Q41988796 |
| | MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancer. | Q42700841 |
| | A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer | Q42735841 |
| | Current challenges in peptide-based drug discovery | Q42778271 |
| | Actin filament cross-linking by MARCKS: characterization of two actin-binding sites within the phosphorylation site domain. | Q43569558 |
| | Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane | Q43785024 |
| | Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma | Q44218241 |
| | Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability | Q44588542 |
| P433 | issue | 4 | |
| P304 | page(s) | 737-747 | |
| P577 | publication date | 2017-10-16 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers | |
| P478 | volume | 36 | |